Application study of a novel apoptogenic protein for the pathogenesis of atherosclerotic diseases

新型凋亡蛋白在动脉粥样硬化疾病发病机制中的应用研究

基本信息

  • 批准号:
    18590810
  • 负责人:
  • 金额:
    $ 2.49万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2006
  • 资助国家:
    日本
  • 起止时间:
    2006 至 2007
  • 项目状态:
    已结题

项目摘要

Apop is a protein originally isolated as a factor of unlkown function from cultured atherosclerotic smooth muscle cells. We found recently that expression of Apop induces apoptosis of vascular smooth muscle cells (SMC) in culture by releasing cytochrome c from mitochondria. Release of cytochrome c from the permeability transition pore (PTP) is believed to play an important role in ischemia/reeoxygenation-induced cardiomyocyte apoptosis, which contributes the development of heart failure following balloon angioplasty after myocardial infarction. This study was performed to investigate the role of Apop in hypoxia/reoxygenation-induced death of cardiomyocytes. Neonatal cardiomyccybas were prepared from ventricles of 2- to 3-day-old Sprague-Dawley rats and maintained in DMEM supplemented with 10% fetal bovine serum. Antisense plasmid to prevent Apop expression or control vector was introduced into cardiomyocybes using an electroporator. Cells were then incubated in hypoxic condition (1% O2 … More ) for 48 hours followed by 2 hours of reoxygenation. Cell viability was assessed by MTT assay. Anti-apoptotic bcl-2 family proteins, such as bcl-2 and bcl-xL were unable to prevent Apop-induced apoptosis, while it was prevented by inhibitors of cyclophilin D, an important component of PTP. These findings indicate that the apoptosis induced by Apop is not mediated by bcl-2 family-related channels, but may require PIP on mitochondrial membrane. Introduction of siRNA targeted toward Apop transcript into cultured cells almost completely abolished the green fluorescence of Apop-GFP fusion protein, indicating that siRNA prevents the expression of Apop. The inhibitory activity of siRNA was also confirmed by Western blot analysis. In the experiments of hypoxia/reoxygenation-induced cell death, introduction of siRNA inhibited the activation of caspase-cascade and the death of cultured cardiomyccytes, whereas introduction of control siRNA affected neither caspase activity nor viability; Inhibition of Apop expression prevented hypoxia/reoxygenation-induced death of cardiomyocytes, suggesting that Apop protein may play roles in the development of cardiac diseases following ischemia-reperfusion injury. Less
APOP是一种蛋白质,最初是从培养的动脉粥样硬化平滑肌细胞中分离出的不屈服功能的因素。最近,我们发现,通过从线粒体释放细胞色素C,凋亡在培养中诱导的血管平滑肌细胞(SMC)的凋亡表达。据信,从渗透性过渡孔(PTP)中释放细胞色素C在缺血/脱氧诱导的心肌细胞凋亡中起重要作用,在心肌梗死后气球血管成形术后,心力衰竭的发展有助于心力衰竭的发展。进行了这项研究,以研究APOP在缺氧/重氧诱导的心肌细胞死亡中的作用。从2至3天大的sprague-dawley大鼠的心室制备新生儿心脏肌cybas,并在补充10%胎牛血清的DMEM中保持。使用电氧化剂将防止APOP表达或对照载体的抗义质粒引入心肌围候。然后将细胞在低氧条件下(1%O2…更多)孵育48小时,然后进行2小时的重氧。通过MTT分析评估细胞活力。抗凋亡BCL-2家族蛋白(例如BCL-2和BCL-XL)无法预防凋亡诱导的凋亡,而Cyclophilin D的抑制剂则阻止了ptp的重要组成部分。这些发现表明,APOP诱导的凋亡不是由Bcl-2家族相关的通道介导的,而是在线粒体膜上需要PIP。将靶向APOP转录物靶向培养细胞的siRNA的引入几乎完全消除了APOP-GFP融合蛋白的绿色荧光,这表明siRNA阻止了APOP的表达。通过Western印迹分析也证实了siRNA的抑制活性。在缺氧/重氧诱导的细胞死亡的实验中,siRNA的引入抑制了caspase-cascade的激活和培养的心肌cy的死亡,而对控制siRNA的引入既不影响caspase活性,也没有影响生存能力。抑制APOP表达可防止缺氧诱导的心肌细胞死亡,这表明APOP蛋白可能在缺血 - 再灌注损伤后在心脏病的发展中起作用。较少的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Apop-1, a novel protein inducing cyclophilin D-dependent but Bax/Bak-related channel-independent apoptosis
  • DOI:
    10.1074/jbc.m512610200
  • 发表时间:
    2006-08-18
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Yasuda, Osamu;Fukuo, Keisuke;Ogihara, Toshio
  • 通讯作者:
    Ogihara, Toshio
Tissue inhibitor of metalloproteinase-3 deficiency inhibits blood pressure elevation and myocardial microvascular remodeling induced by chronic administration of Nomega-nitro-L-arginine methyl ester in mice.
金属蛋白酶-3 缺乏组织抑制剂可抑制小鼠长期服用 Nomega-硝基-L-精氨酸甲酯诱导的血压升高和心肌微血管重塑。
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yatomi;M;Takiguchi;Y et. al.;Higuchi M
  • 通讯作者:
    Higuchi M
Tissue inhibitor of metalloproteinase-3 plays important roles in the kidney following unilateral ureteral obstruction
  • DOI:
    10.1291/hypres.29.285
  • 发表时间:
    2006-04-01
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Kawamoto, Hidenobu;Yasuda, Osamu;Maeda, Nobuyo
  • 通讯作者:
    Maeda, Nobuyo
血管内膜肥厚におけるApop遺伝子の発現解析
Apop基因在血管内膜增厚中的表达分析
  • DOI:
  • 发表时间:
    2007
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Miyanaga K;Tanino H;Yokomizo S ,Fukuo K;安田 修
  • 通讯作者:
    安田 修
Timp-3欠損マウスの血圧解析
Timp-3 缺陷小鼠的血压分析
  • DOI:
  • 发表时间:
    2006
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Yasuda;O;Fukuo;K;Higuchi;M;Yotsui;T. Rakugi;H;Othhara;T;安田 修
  • 通讯作者:
    安田 修
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YASUDA Osamu其他文献

YASUDA Osamu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YASUDA Osamu', 18)}}的其他基金

Physics beyond the standard model probed by neutrinos
中微子探测的物理超出标准模型
  • 批准号:
    24540281
  • 财政年份:
    2012
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Creation of the anti-aging therapy that assumed Apop gene as a target
创造以Apop基因为靶标的抗衰老疗法
  • 批准号:
    23590886
  • 财政年份:
    2011
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Phenomenology of physics which can be probed by neutrino experiments
可以通过中微子实验探测的物理现象学
  • 批准号:
    21540274
  • 财政年份:
    2009
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Applied Reserch of Apop protein for the treatment of Atherosclerosis
Apop蛋白治疗动脉粥样硬化的应用研究
  • 批准号:
    20590882
  • 财政年份:
    2008
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Study of the molecular mechanism and clinical implication of a novel apoptosis gene
新型凋亡基因的分子机制及临床意义研究
  • 批准号:
    16601001
  • 财政年份:
    2004
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Phenomenology related to neutrino oscillation experiments in the near future
近期中微子振荡实验相关的现象学
  • 批准号:
    16540260
  • 财政年份:
    2004
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Neutrino Physics Related to Long Baseline Experiments
与长基线实验相关的中微子物理
  • 批准号:
    13640295
  • 财政年份:
    2001
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Physics related to the atmospheric neutrino anomaly
与大气中微子异常相关的物理
  • 批准号:
    10640280
  • 财政年份:
    1998
  • 资助金额:
    $ 2.49万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

炎症靶向的工程化囊泡通过线粒体自嗜智能响应脑缺血再灌注后的神经元凋亡
  • 批准号:
    82301561
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
花期灌溉诱导的线粒体凋亡在香梨形成宿萼果与脱萼果中的机制
  • 批准号:
    32360722
  • 批准年份:
    2023
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
补铁调控线粒体-内质网膜结构偶联在主动脉平滑肌细胞凋亡中作用机制的研究
  • 批准号:
    82300539
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
LncRNA-MEG3-tRNA-LUC7L3功能轴调控线粒体凋亡参与糖尿病缺血性脑损伤的机制研究
  • 批准号:
    82371477
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
卵形鲳鲹Bcl-2/Bok介导的线粒体凋亡途径参与机体免疫应答的作用和机制研究
  • 批准号:
    32303047
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Complement Protein C1q Regulation of Macrophage Metabolic Pathways
补体蛋白 C1q 对巨噬细胞代谢途径的调节
  • 批准号:
    10629550
  • 财政年份:
    2023
  • 资助金额:
    $ 2.49万
  • 项目类别:
PET Tracer for Imaging of Lung Inflammation
用于肺部炎症成像的 PET 示踪剂
  • 批准号:
    10682270
  • 财政年份:
    2023
  • 资助金额:
    $ 2.49万
  • 项目类别:
Targeted Mitochondrial Delivery Systems for Vascular Interventions
用于血管干预的靶向线粒体输送系统
  • 批准号:
    10905155
  • 财政年份:
    2023
  • 资助金额:
    $ 2.49万
  • 项目类别:
Investigating the role of apoptosis regulation in cancer therapy-induced vascular toxicities
研究细胞凋亡调节在癌症治疗引起的血管毒性中的作用
  • 批准号:
    10537996
  • 财政年份:
    2022
  • 资助金额:
    $ 2.49万
  • 项目类别:
The role of epigenetics in RPE heterogeneity with early AMD
表观遗传学在早期 AMD RPE 异质性中的作用
  • 批准号:
    10630096
  • 财政年份:
    2022
  • 资助金额:
    $ 2.49万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了